EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Anticoagulation during extracorporeal membrane oxygenation: A narrative review

John R Priest iD, David Hebert, Camille Jutras

Perfusion · 2025

DOI: 10.1177/02676591241250288 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Perfusion, 2025. Verfasst von John R Priest und 2 weiteren Autor:innen. Beteiligte Einrichtung: ECMO Program, Department of Respiratory Care, Lifespan Hospital System, Providence, RI, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Anticoagulants, Blood Coagulation, Heparin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracorporeal Membrane Oxygenation (ECMO) is a technology that offers organ support for critically ill patients with respiratory and/or cardiac failure. Despite improvements in recent years in technology and the biocompatibility of circuits, patients on ECMO remain at high risk of hematologic complications, such as bleeding or thrombosis. Anticoagulation is required in most cases to limit the risk of clotting, but questions persist regarding the optimal anticoagulation strategy. More precisely, there is still debate around the best anticoagulation agent and monitoring tools as well as on the transfusion thresholds and appropriate corrective measures when faced with complications. This narrative review provides an overview of hemostasis on ECMO and the impact of circuit size and coating. The benefits and downsides of unfractionated heparin (UHF) and Direct Thrombin Inhibitors (DTIs) as anticoagulation agents are reviewed. Finally, commonly available coagulation tests (activated clotting time, activated partial thrombin time, anti-Xa, and viscoelastic tests) and their limitations are addressed. In conclusion, future research is needed to determine the best anticoagulation strategy for patients on ECMO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationAnticoagulantsBlood CoagulationHeparinHumansThrombosis

Stichwörter der Autor:innen

Extracorporeal membrane oxygenationanticoagulationanticoagulation monitoringbivalirudinbleedingextracorporeal life supporthemostasisheparinreviewthrombosis

Substanzen

AnticoagulantsHeparin

Autor:innen und Institutionen

  • ECMO Program, Department of Respiratory Care, Lifespan Hospital System, Providence, RI, USA.
  • ECMO Program, Our Lady of the Lake Regional Medical Center, Baton Rouge, LA, USA.
  • Innovative ECMO Consults, Bluffton, SC, USA.
  • Department of Anesthesiology, Boston Children's Hospital, Critical Care and Pain Medicine, Boston, MA, USA.

ORCID-Profile: John R Priest

Zitieren

APA

Priest, J. R., Hebert, D., & Jutras, C. (2025). Anticoagulation during extracorporeal membrane oxygenation: A narrative review. Perfusion. https://doi.org/10.1177/02676591241250288

Vancouver

Priest JR, Hebert D, Jutras C. Anticoagulation during extracorporeal membrane oxygenation: A narrative review. Perfusion. 2025. doi:10.1177/02676591241250288

BibTeX
@article{Priest2025,
  author = {Priest, John R and Hebert, David and Jutras, Camille},
  title = {Anticoagulation during extracorporeal membrane oxygenation: A narrative review},
  journal = {Perfusion},
  year = {2025},
  doi = {10.1177/02676591241250288}
}
Kostenlos starten →